What therapy would you recommend for metastatic myxoid liposarcoma in a young patient with anthracycline cardiomyopathy with EF 25% who failed eribulin?  

Would you even consider trabectedin in this case given its cardiotoxicity?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution